» Articles » PMID: 30379616

Phospholipid Remodeling in Physiology and Disease

Overview
Publisher Annual Reviews
Specialty Physiology
Date 2018 Nov 1
PMID 30379616
Citations 163
Authors
Affiliations
Soon will be listed here.
Abstract

Phospholipids are major constituents of biological membranes. The fatty acyl chain composition of phospholipids determines the biophysical properties of membranes and thereby affects their impact on biological processes. The composition of fatty acyl chains is also actively regulated through a deacylation and reacylation pathway called Lands' cycle. Recent studies of mouse genetic models have demonstrated that lysophosphatidylcholine acyltransferases (LPCATs), which catalyze the incorporation of fatty acyl chains into the sn-2 site of phosphatidylcholine, play important roles in pathophysiology. Two LPCAT family members, LPCAT1 and LPCAT3, have been particularly well studied. LPCAT1 is crucial for proper lung function due to its role in pulmonary surfactant biosynthesis. LPCAT3 maintains systemic lipid homeostasis by regulating lipid absorption in intestine, lipoprotein secretion, and de novo lipogenesis in liver. Mounting evidence also suggests that changes in LPCAT activity may be potentially involved in pathological conditions, including nonalcoholic fatty liver disease, atherosclerosis, viral infections, and cancer. Pharmacological manipulation of LPCAT activity and membrane phospholipid composition may provide new therapeutic options for these conditions.

Citing Articles

Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment.

Rostami Ravari N, Sadri F, Mahdiabadi M, Mohammadi Y, Ourang Z, Rezaei Z Front Cell Dev Biol. 2025; 13:1522873.

PMID: 40078365 PMC: 11897296. DOI: 10.3389/fcell.2025.1522873.


Organ-Specific Responses to Chronic High-Fat Diets in Mice: Insights into Phospholipid Fatty Acid Distribution.

Nenadovic A, Kovacevic S, Stankovic A, Popovic T, Debeljak Martacic J, Rankovic S Nutrients. 2025; 17(5).

PMID: 40077693 PMC: 11901986. DOI: 10.3390/nu17050821.


Xanthohumol Sensitizes Melanoma Cells to Vemurafenib by Lowering Membrane Cholesterol and Increasing Membrane Fluidity.

Devinat M, Thevenard-Devy J, Ghilane F, Devy J, Chazee L, Terryn C Int J Mol Sci. 2025; 26(5).

PMID: 40076912 PMC: 11901044. DOI: 10.3390/ijms26052290.


AAV capsid prioritization in normal and steatotic human livers maintained by machine perfusion.

Kim J, Kurial S, Choksi P, Nunez M, Lunow-Luke T, Bartel J Nat Biotechnol. 2025; .

PMID: 39881029 DOI: 10.1038/s41587-024-02523-6.


LPCAT1, the Enzyme Responsible for Converting LPC to PC, Promotes OPC Differentiation In Vitro.

Shang Q, Zhang X, Pu Y, Lin J, Ma P, Pan Y J Cell Mol Med. 2025; 29(3):e70387.

PMID: 39878319 PMC: 11775935. DOI: 10.1111/jcmm.70387.


References
1.
Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez de Fonseca F . Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature. 2003; 425(6953):90-3. DOI: 10.1038/nature01921. View

2.
Jacobs R, Devlin C, Tabas I, Vance D . Targeted deletion of hepatic CTP:phosphocholine cytidylyltransferase alpha in mice decreases plasma high density and very low density lipoproteins. J Biol Chem. 2004; 279(45):47402-10. DOI: 10.1074/jbc.M404027200. View

3.
Begg D, Woods S . The endocrinology of food intake. Nat Rev Endocrinol. 2013; 9(10):584-97. DOI: 10.1038/nrendo.2013.136. View

4.
Huang H, Sun F, Owen D, Li W, Chen Y, Gale Jr M . Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci U S A. 2007; 104(14):5848-53. PMC: 1829327. DOI: 10.1073/pnas.0700760104. View

5.
Syed G, Amako Y, Siddiqui A . Hepatitis C virus hijacks host lipid metabolism. Trends Endocrinol Metab. 2009; 21(1):33-40. PMC: 2818172. DOI: 10.1016/j.tem.2009.07.005. View